- Home
- MDGL vs CR Comparison
MDGL vs CR Comparison
Compare MDGL & CR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | MDGL | CR |
|---|---|---|
| Founded | 2011 | 1855 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Metal Fabrications |
| Sector | Health Care | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 9.6B | 10.5B |
| IPO Year | N/A | N/A |
Fundamental Metrics
Financial Performance| Metric | MDGL | CR |
|---|---|---|
| Price | $582.30 | $181.94 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 13 | 5 |
| Target Price | ★ $543.33 | $223.60 |
| AVG Volume (30 Days) | ★ 415.7K | 292.5K |
| Earning Date | 11-04-2025 | 10-27-2025 |
| Dividend Yield | N/A | ★ 0.51% |
| EPS Growth | N/A | ★ 37.96 |
| EPS | N/A | ★ 6.25 |
| Revenue | $740,640,000.00 | ★ $2,268,100,000.00 |
| Revenue This Year | $395.75 | $10.83 |
| Revenue Next Year | $65.73 | $12.96 |
| P/E Ratio | ★ N/A | $29.07 |
| Revenue Growth | ★ 864.21 | 19.64 |
| 52 Week Low | $265.00 | $127.04 |
| 52 Week High | $605.00 | $203.89 |
Technical Indicators
Market Signals| Indicator | MDGL | CR |
|---|---|---|
| Relative Strength Index (RSI) | 66.51 | 46.33 |
| Support Level | $569.04 | $173.64 |
| Resistance Level | $598.77 | $184.32 |
| Average True Range (ATR) | 26.64 | 4.90 |
| MACD | 0.06 | -0.07 |
| Stochastic Oscillator | 75.05 | 45.20 |
Price Performance
Historical ComparisonAbout MDGL Madrigal Pharmaceuticals Inc.
Madrigal Pharmaceuticals Inc is a biopharmaceutical company focused on delivering novel therapeutics for metabolic dysfunction-associated steatohepatitis (MASH), a serious liver disease with high unmet medical need that can lead to cirrhosis, liver failure, and premature mortality. The company's medication, Rezdiffra (resmetirom), is a once-daily, oral, liver-directed thyroid hormone receptor agonist designed to target key underlying causes of MASH.
About CR Crane Company
Crane is a diversified industrial firm that manufactures a broad range of products, including valves, pumps, aerospace components, and fiberglass-reinforced plastic panels. Its business is organized into two segments: aerospace and electronics, and process flow technologies. Crane generated approximately $2.1 billion in revenue in 2024.